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                                        INTRODUCTION 
Rheumatoid arthritis is a chronic inflammatory polyarthritis leading to deformities. It is defined 
by the American College of Rheumatology (ACR) as a diffuse connective disease, and around 
40%  of  patients  are  considered  to  have  characteristic  extra-articular  manifestations.  The 
predominant extra-articular manifestations involve the lungs, nerves, blood vessels, heart, skin, 
eyes1. 
Neuropathy is one of the important extra-articular manifestations of Rheumatoid arthritis and 
can have crippling consequences44,72.  Subjective and objective assessment of neuropathy in RA 
is difficult  due to concomitant joint disease as both may contribute to muscle wasting and 
weakness. Neuropathy in RA is most commonly due to vasculitis, entrapment or due to drugs. 
Various types of neuropathy can occur from mononeuritis multiplex to severe sensorimotor 
neuropathy. Although there might be some recovery of the predominant sensory neuropathy, 
severe mixed neuropathy or mononeuritis multiplex appears to be a reflection of an aggressive 
vasculitic  form of  RA and  is  associated  with  poor  prognosis.  Hence  it  is  imperative  that 
rheumatoid neuropathy is detected at the earliest when it is sub clinical. Electrophysiological 
studies  are  important  for  confirmation  of  clinical  suspicion  and  to  detect  sub  clinical 
neuropathy.
Paucity of Indian literature on rheumatoid neuropathy creates a lacuna in the critical evaluation 
and discussion of the subject. Hence this study was carried out to find out the incidence and 
pattern of neuropathy in our RA patients. Another aim was to find out any correlation between 
neuropathy and disease parameters like duration, activity, rheumatoid factor. 
                     AIMS OF THE STUDY.
 To find out the incidence and pattern of neuropathy in Rheumatoid arthritis.
 To correlate neuropathy with disease parameters of Rheumatoid arthritis and other extra-
articular manifestations.
                                       
                                REVIEW OF LITERATURE
HISTORY
           Sporadic references to peripheral neuropathy complicating RA appeared as early as the 
last century.  Pitres & Vaillard (1886) and later Bannatype (1898) reported involvement of 
peripheral nerves in RA. In 1942, Ball called attention to the clinical significance of systemic 
involvement that included peripheral nerves. In 1952, Hart, Golding & Mckenzie39 were the 
first to describe a definite series of ten patients with peripheral neuropathy complicating RA 
and  was  thought  to  be  caused  by  diffuse  arteritis.  In  1965,  Bennet  &  Scott  described 
rheumatoid  neuropathy  associated  with  autonomic  neuropathy.  In  1965,  C.A.Pallis   & 
J.J.Scott14 described 30 cases of RA with peripheral neuropathy. They described 5 patterns of 
neural involvement namely 
1. Upper limb with lesions in major peripheral nerve.
2. Upper limb with digital neuropathy.
3. Lower limb with lesions in major peripheral nerve.
4. Lower limb with distal sensory neuropathy.
5. Distal sensorimotor Polyneuropathy of upper limb & lower limb.
Marmor et al in 1967, Chamberlain & Carbett42 in 1970, Lloyd & Agarwal2 in 1970 defined 
rheumatoid neuropathy as  a  separate  entity  & it  should not  be  confused with compressive 
neuropathy.
RHEUMATOID ARTHRITIS: A SHORT GENERAL DESCRIPTION
EPIDEMIOLOGY : 
RA is  a  chronic  inflammatory disorder  affecting primarily  the  synovial-lined joints.  RA is 
widely  distributed  all  over  the  world  and  affects  all  races6.  The  prevalence  in  the  adult 
population  is  assessed  at  approximately  0.8  to  1.0%.  The  incidence  varies  in  different 
geographical areas from 27 to 8 / 1000009. Prevalence and incidence are about 3 times higher in 
women than in men and increases with age. 
ETIOLOGY :
Both  genetic  predisposition  and  environmental  factors  are  likely  to  play  a  role10.  RA  is 
associated  with  HLA-DR4.  Patients  with  DR-4  positive  show  more  disease  activity  and 
continued progression of arthrogenic changes12. Possible environmental factors are infectious 
agents, but evidence for a role of any specific microorganism has not been discovered yet.16
PATHOGENESIS:
Very schematically, the following might happen: an as yet unidentified, arthritogenic stimulus 
triggers  an  immuno-inflammatory  cascade  in  an  immuno-genetic  susceptible  individual. 
Inflammation  is  mediated  by  inflammatory  cells,  prostaglandins,  and  cytokines.  The 
inflammation causes local joint damage and widespread bone loss.21,25
Rheumatoid factor (RF), one of the altered immunoglobins in RA, is an auto-antibody against 
IgG. It is present in approximately 80% of RA patients, and is not specific for RA despite its 
name.  RF’s  are  involved  in  immune-complex  formation  and  induce  recruitment  of 
macrophages and other white blood cells28. RA patients with a positive test for RF in blood 
have a  severe  clinical  disease30.  Extra-articular  manifestations  occur  mostly  in  RF positive 
patients  with  progressive  joint  inflammation,  suggesting  these  manifestations  are  immune- 
mediated.
PATHOLOGY :
PANNUS: The  synovia  become  thickened,  in  part  due  to  inflammatory  infiltrate  and  to 
oedema, but also because of growth of blood vessels, proliferation of synovial fibroblasts, and 
multiplication  and  enlargement  of  synovial  lining  cells.  This  granulation  tissue  is  called 
pannus. The pannus attacks the cartilage causing destruction and also invade the bone cortex 
near the joints.
NODULES: Nodules  are  found in  20-30% of  patients  with definite  seropositive  RA.  The 
nodule has a yellow, necrotic centre that has at microscopy a fibrinoid aspect.  It  is  mainly 
located subcutaneously at pressure points: at the extensor side of the olecranon, the proximal 
part of the ulna.31,32
VASCULITIS: vasculitis in RA may affect arteries of all sizes as well as small vessels, but has 
a  preference  for  medium  and  small  arteries35.  Though  all  layers  may  be  infiltrated, 
inflammation is  generally greatest in the adventitia.  It  is  considered to be mediated by the 
deposition of circulating immune complexes37.
CLINICAL FEATURES AND DIAGNOSIS :
              RA presents with systemic manifestations or with symptoms and signs of arthritis of 
metacarpophalangeal joints, proximal interphalangeal joints or wrists25. More proximal, larger 
joints  may  become  involved  with  time.  Onset  is  gradual  or  occasionally  acute.  Joint 
inflammation causes morning stiffness, limitation of movement, pain, swelling, redness, and 
deformity. Not all of these changes are always detectable at examination.  Active vasculitis is 
seen in all patients with joint deformities and high RF titre, and is, in some cases (not always), 
acute and dramatic in onset. It may cause a large number of clinical manifestations, including 
nail  fold  teleangiectasia,  digital  gangrene,  purpura,  skin  ulcers,  visceral  infarcts,  and 
mononeuritis multiplex. CNS involvement is rare but has been reported. 
           Laboratory examination in patients with RA shows increase of erythrocyte sedi-
mentation rate (ESR) and some degree of anemia and leukocytosis. A raised RF is in favour of 
the diagnosis. X-rays reveal periarticular osteopenia and marginal erosions. 
             Diagnosis is made mainly on clinical grounds. As a rule, joints are affected in a 
symmetrical fashion or with some degree of asymmetry. The main exceptions to this rule are 
the joints in the paretic side of hemiplegic individuals, which are much less involved probably 
due to limitation of activity.
The 1988 revised ACR classification criteria71 for definite RA are given below.
NO CRITERION DEFINITION
1. MORNING 
STIFFNESS
Morning stiffness in and around the joints lasting at 
least 1 hour before maximal improvement.
2 ARTHRITIS OF 3
MAJOR JOINTS
At least 3 joint areas having soft tissue swelling or 
fluid  observed  by  a  physician  among 
PIP,MCP,WRIST,KNEE,ANKLE,AND  MTP 
JOINTS
3 ARTHRITIS OF 
HAND JOINTS
At least one joint area swollen as above in wrist, 
MCP,PIP
4 SYMMETRICAL 
ARTHRITIS
Simultaneous involvement  of  same joint  areas  on 
both sides
5 RHEUMATOID 
NODULES
Subcutaneous  nodules  over  bony  prominences 
observed by physician
6 RHEUMATOID 
FACTOR
Demonstration of abnormal amounts of serum RF 
by a method that has been positive in less than 5 % 
of normal subjects
7 RADIOGRAPHIC 
CHANGES
Erosions or unequivocal bony calcification
EXTRA-ARTICULAR MANIFESTATIONS OF RA are as follows.
I. Essential to systemic rheumatoid disease
Nodules
            Pericarditis, pleuritis
            Vasculitis including neuropathy .
II. Other features and associated syndromes
Anemia
            Lymphadenopathy
            Osteopenia
            Sjogren’s syndrome
            Interstitial lung fibrosis
            Amyloidosis
            Felty’s syndrome.
THERAPY
Therapy aims at  relief  of pain and stiffness and preservation or  improvement  of function. 
Scales have been developed to assess the functional status of patients and to measure disease 
activity39.  Non-pharmaceutical  interventions (psychosocial  assistance,  physical  therapy, 
occupational therapy, splints and orthoses, surgery) have an important place in treatment plans. 
Pharmaceutical  interventions  are  either  local  (intra-articular  injections,  ulcer  treatment)  or 
systemic. Among the latter, one makes a distinction between non-steroidal inflammatory drugs 
(NSAIDs),  corticosteroids,  and  a  heterogeneous  group  of  disease-modifying  antirheumatic 
drugs (DMARDs), which are also called slow-acting antirheumatic drugs (SAARDs). Drugs 
belonging to this last group are hydroxychloroquine, gold salts, sulfasalazine, D-penicillamine, 
azathioprine, methotrexate, cyclosporine, and cyclophosphamide. Early intensive therapy with 
prednisolone and methotrexate is at present advocated.
COURSE OF THE DISEASE AND PROGNOSIS
           In some patients,  the course is  intermittent (15-20%); occasionally,  it  has long clinical 
remissions (10%); but in most patients, it is progressive (60-70%). Life expectancy is shortened, more 
for  males  than for  females.  Seropositivity and onset  at  a young age are  associated with a  poorer 
prognosis. 
NEUROLOGY OF RHEUMATOID ARTHRITIS
1. MOOD AND COGNITION:  
Patients with RA are more often depressed and anxious than age and sex matched controls40. Feelings 
of distress are increased by pain, disability, and fatigue. Mild cognitive deficits were found in a recent 
well-controlled,  extensive  neuropsychological  investigation of  a  group of  nonneurological  patients 
with RA41. The result came as a surprise and could not be explained as an effect of psychological 
distress. 
2. MENINGEAL NODULES, PACHYMENINGITIS, AND CNS VASCULITIS.  
Rheumatic nodules occur occasionally in the dura, falx cerebri, the leptomeninges, and the 
choroid  plexus43.  Some  of  the  nodules  adhere  to  the  brain  or  spinal  cord  and  compress 
structures,  but  they do not  intrude into the  parenchyma and probably do not  occur  in the 
parenchyma of the nervous tissue. In some cases, not only nodules are present; there is also a 
more widespread, plaque-like inflammation of the meninges with necrosis, lymphocytes, and a 
variable percentage of plasma cells. This aseptic pachymeningitis may also occur on its own 
without  any  rheumatic  nodules.44 Vasculitis,  extending in some cases from a region of 
pachymeningitis into the brain, has also been reported. 
        Mental obtundation, Organic brain syndrome, severe headache , seizures , cranial 
neuropathy including optic neuropathy  ,  paresis and agnosia, thoracic myelopathy, and 
radiculopathy due to rheumatic nodules or pachymeningitis have all been reported. The 
number of patients with these syndromes is  small  and few reports are of recent date. 
Inflammatory  CNS  disease  as  described  here  occurs  usually,  but  not  exclusively,  in 
patients  with  longstanding  seropositive  disease  and  considerable  deformities.  Not  all 
patients with inflammatory CNS disease have subcutaneous nodules.
When performed, CSF examination reveals a raised protein content and a modest degree 
(or no) pleocytosis. Imaging has been helpful in a few cases by showing enhancement of 
meningeal  structures.  In  the  reported  cases,  vasculitis  has  never  been  discovered  by 
angiography.  In  fact,  the  introduction  of  new  imaging  techniques  has  somewhat 
simplified  making  the  diagnosis  of  cerebral  vasculitis.  These  new  techniques  have 
stimulated interest in cerebral vasculitis  but have not increased the publication of new 
cases  of  rheumatoid  vasculitis,  and  this  casts  some  doubt  on  the  entity  'rheumatoid 
cerebral vasculitis'. Meningeal rheumatic nodules are sometimes discovered at autopsy in 
patients without any neurological manifestations. 
3. NORMAL PRESSURE HYDROCEPHALUS AND RHEUMATOID ARTHRITIS  
Normal pressure hydrocephalus is characterized by dementia, unstable gait, and, urinary 
incontinence, and can be treated by ventriculo-peritoneal shunting. It was described by 
Rasker  et al. in six patients with RA46.  The relation between the two diseases, if any, 
remains  unclear.  In  1995,  Markusse  et  al,  reported on two further  possible  cases  and 
suggested  that  it  might  be  caused  by  obstruction  of  CSF  absorption  by  chronic 
meningitis48.  The authors  observed improvement in their  patients  upon treatment  with 
corticosteroids,  and considered this  as  support  for  their  hypothesis.  In established and 
published cases of 'rheumatoid meningitis', normal pressure hydrocephalus has so far not 
been observed and reported. 
4. RHEUMATOID  ARTHRITIS  OF  THE  CERVICAL  SPINE  .AND   
THORACOLUMBAR SPINE.
Epidemiology 
Cervical  spine lesions in patients  with long-standing RA often form a point  of great 
concern.  Two years  after  the diagnosis  of RA has been established,  10% of patients 
already  show  a  mild  degree  of  one  of  the  different  forms  of  cervical  rheumatoid 
subluxations53. After approximately 10 years, one third of the patients have a form of 
cervical subluxation, and after mean disease duration of 15.7 years, the prevalence of 
cervical subluxation is 52%, as was shown in a population-based study in Finland. The 
severity of  the  neck lesions  correlates  with the  degree of  erosion of  metacarpo-  and 
metatarsophalangeal joints. In contrast to cervical rheumatoid arthritis, thoracic arthritis 
rarely causes subluxation. 
The reason for the excessive vulnerability of the cervical spine is not definitely  clarified, 
but two factors are likely to play a significant role: the extreme mobility of the cervical 
spine and the heavy load it  has  to carry.  It  is  of interest  that  the protective effect  of 
hemiplegia on the development of rheumatoid joint lesions is explained by the decreased 
use of the joints on the same side of the body57. 
Destructive changes
Destructive changes occur in particular at the atlanto-occipital and atlanto-axial levels and 
to a lesser degree in the sub axial cervical segments. At each cervical segment, from the 
atlanto-occipital level downward, there are two lateral synovia-lined joints. The dens has, 
in addition, a small synovia-lined joint with the anterior arch of the atlas and another one 
with  the  strong  transverse  ligament  that  covers  the  dens  at  the  posterior  side59.  This 
transverse  ligament  prevents  posterior  movement  of  the  odontoid  process  towards  or 
against the spinal cord during flexion of the cervical spine. From C2 downward there are 
small synovia-lined joints between the lateral edges of the cervical vertebrae. All these 
synovia-lined  joints,  as  well  as  nearby  ligaments,  cartilage,  and  bone,  may  become 
affected and destroyed  by the  inflammatory rheumatoid  process60.  This  may result  in 
abnormal mobility and some degree of subluxation of cervical vertebrae, which poten-
tially endangers the spinal cord.
Bulbo-myelopathy and radiculopathy 
The  neurological  manifestations  are  in  broad  outline  similar  to  other  cranio-vertebral 
syndromes. Displacement of vertebrae may narrow the space available for the radices in 
foramina intervertebralia,  for  the  spinal  cord in the  spinal  canal,  and for  the  medulla 
oblongata  in  the  foramen  magnum.  Compression  of  nervous  structures  may  be 
intermittent,  as  in  patients  with  reducible  AAS,  or  permanent,  as  in  most  vertebral 
subluxations. Neurological symptoms and signs may therefore be intermittent also, though 
they are mostly definite. 
       Neurological  evaluation  of  handicapped,  deformed  patients  with  long-standing 
rheumatoid arthritis and atrophy of peri-articular muscles is not easily performed. This is 
reflected by the descriptions in the literature on the neurology of the cervical spine lesions, 
which are usually put in very general terms62. Spinal cord compression develops only in a 
small minority of patients, after many years or even decades. Winfield et al followed a 
group of 100 patients from the first year after RA had been diagnosed. At the end of a 10 
year period, one patient had developed cervical myelopathy.
Five forms of cervical subluxation
1. Anterior atlanto-axial subluxation (AAS) is caused mainly by laxity and destruction of 
the transverse ligament. The distance between the posterior side of the atlas and the 
anterior  side of the odontoid process (normal  less than 3 mm) is  increased,  and the 
diameter of the vertical canal (normal 18-26 mm) is decreased. At flexion of the neck, 
AAS increases (reducible AAS). This is the most frequent form of cervical subluxation. 
2. Posterior AAS is due to severe erosion or fracture of the odontoid process that allows 
the atlas to move backward. This form of subluxation is uncommon. 
3.Atlanto-occipital impaction (AAI) or vertical subluxation happens when the cranium 
descends on the cervical  spine and the odontoid process moves upward through the 
foramen magnum (normally, the odontoid process is below the foramen magnum), due 
to  destruction  of  bone  and  cartilage  at  the  occipito-atlanto  and  atlanto-axial  joints. 
Authors  use  different  criteria  for  AAI  and  the  figures  for  its  prevalence  vary 
accordingly. It is probably the second most frequent form of cervical subluxation after 
AAS, and occurs after a longer period of disease than AAS. AAI has a stabilizing effect 
on AAS due to loss of mobility in the atlanto-axial joints. 
4. Lateral AAS is due to unilateral or asymmetrical joint disease and destruction of the 
lateral mass of the atlas at that side. Patients show rotational tilting of the head towards 
the affected side. 
5. Sub  axial  subluxation  is  due  to  intervertebral  joint  lesions  and  weakening  of 
ligaments.  Sub axial subluxation is held to be present when there is displacement of 
adjacent vertebral bodies of more than 3.5 mm as measured from the posterior side of 
the bodies. Sub axial subluxation tends to become more severe  by fixation of the two 
upper cervical vertebrae, either by AAI or by operation. Long-standing cervical RA may 
occasionally result in progressive kyphosis from C2-C7, with compensatory lordosis at 
the craniocervical junction. 
 Neurological symptoms and signs in patients with cervical subluxations 
1. In  comparison  to  the  degree  of  the  cervica1  abnormalities  and  the  evidence  of 
bulbospinal compression, neurological signs are commonly less marked than one would 
expect. Symptoms and signs of the spinal cord and radiculi are much more frequent than 
bulbar syndromes and cranial nerve lesions. 
2.  Myelopathy:  disturbance  of  gnostic  sensibility  is  more  frequent  than  of  vital 
sensibility.  Some  patients  have  unilateral  or  bilateral  astereognosis  of  the  hands. 
Lhermitte's sign may be present.  Pyramidal changes include raised tendon reflexes 
with  positive  Babinski  reflexes,  spasticity,  and  muscle  weakness  in  that  order. 
Disorders of bladder and bowel motility are not rare. 
 3. Radiculopathy: severe pain in the occipital region presumably of radicular origin is 
relatively frequent. 
 4.  Bulbar  syndromes  and  cranial  nerve  lesions:  dysphagia  and  dysarthria,  vertigo, 
fainting, cerebellar signs, symptoms of Cr.N V, IX, X, XII, VII and rarely III, IV and 
VI.  Obstructive  hydrocephalus  and  secondary  inappropriate  antidiuretic  hormone 
secretion have been reported. 
BULBAR SIGNS
The hypoglossus, glossopharyngeus, and the vagus nerves were the most frequently  affected 
cranial nerves, but one of the patients of Menezes  et  al.  had loss of pain and touch in the 
distribution of the trigeminal nerve and another even had facial diplegia. In the group of Rana 
et al, eight of 41 patients with AAS had trigeminal sensory neuropathy. Toolanen determined 
the cutaneous threshold for the face in patients with AAS and AAI due to RA, and discovered 
changes  in  the  ophthalmic  and maxillary  divisions  of  the  trigeminal  nerve  but  not  in  the 
mandibular  division,  presumably  due to  lesions  in  the  trigeminal  spinal  tract.  Obstructive 
hydrocephalus  was  reported  in  three  cases,  and  was  associated  in  one  with  secondary 
inappropriate antidiuretic hormone secretion. Symptoms of dysphagia and dysarthria of uncer-
tain origin were present in 41 (respectively 35) of 186 patients operated for either AAS or 
AAI.
MYELOPATHY 
Menezes et al. found hyperreflexia with positive Babinski signs in 36 of their 45 neurologically 
symptomatic  patients  with  AAI.  The  authors  had  difficulty  in  adequately  evaluating  the 
strength of their patients. Posterior column sensory disorders were frequent, but hypalgesia was 
unusual. Nakano et al also found weakness in patients with hyper-reflexia and Babinski signs. 
Astereognosis of the hands was a feature of 18 of these 32 patients. Other sensory disturbances 
including hypalgesia were often present. Sixteen patients had bladder and/or rectal sphincter 
dysfunction. Lhermitte's sign was present in 35 of 186 patients with myelopathy. 
      5. MYASTHENIA GRAVIS AND RA
 MG is often associated with other auto immune diseases. The RA prevalence in patients with 
MG varies in different studies. It is according to Oosterhuis et al, from 0-10%. MG may be 
induced by treatment with penicillamine.
    6.  MUSCLE ATROPHY, MYOPATHY AND MYOSITIS.
Muscular strength and endurance in RA are, in general, less than in a control population, and 
patients have less muscle volume. These changes are conceived to be due to factors related to 
the  inflammatory  process  and  to  inactivity.  Muscles  around  arthritic  joints  may  become 
obviously atrophic; this is one of the most common features of RA. Miro et al showed that 
proximal  weakness  is  due  to  either  myositis  (DM  or  PM)  or  to  an  unwanted  effect  of 
medication  (corticosteroids,  D-Penicillamine,  Chloroquine).  The  association  of  RA  and 
inclusion body myositis (IBM) has been reported.
   7.  NEUROPATHY IN RHEUMATOID ARTHRITIS.
The most acceptable classification of Rheumatoid neuropathy is as follows.
1. ENTRAPMENT NEUROPATHY
a. Carpal tunnel syndrome
b. Tarsal tunnel syndrome.
c. Posterior interosseus nerve entrapment
d. Other nerves.
2. NON-ENTRAPMENT NEUROPATHY.
a. Sensory  neuropathy
b. Motor neuropathy.
c. Sensorimotor neuropathy
d. Mononeuropathy
e. Mononeuropathy multiplex.
NON-ENTRAPMENT NEUROPATHY.
EPIDEMIOLOGY: 
Sensory and sensorimotor neuropathies do not often produce management problems in RA and 
for that reason the epidemiology of these disorders is not fully elucidated yet. Conn and Dyck61 
detected 25 cases of symptomatic peripheral neuropathy in a survey of 2162 RA patients all 
seen in Mayo clinic in 1971. The findings of Bekkelund et al63 concerning nerve conduction in 
52 women with seropositive and erosive RA and the lack of any evidence of neuropathy in this 
group support the view that peripheral neuropathies are infrequent. On the other hand Fleming 
et al 64, in a large longitudinal investigation of extra-articular features during the first five or six 
years after onset of RA, diagnosed distal sensory and distal motor neuropathies in 18 of 102 
patients. Distal sensory neuropathy was more frequent than sensorimotor or motor neuropathy. 
This confirmed previous observations by Pallis and Scott 65, Chamberlain and Bruckner (1970), 
and  Weller  et  al  (1970)  indicating  that  a  relatively  mild  sensory  neuropathy  could  be 
distinguished from severe forms with motor and sensory symptoms.
CLINICAL FEATURES AND COURSE.
Mild  sensory  neuropathy  is  stated  to  recover  mostly  spontaneously67 and  to  occasionally 
become severe and sensorimotor61.  Some of the more severe sensorimotor polyneuropathies 
present at onset as mononeuritis multiplex. In such cases, the patient complains suddenly about 
pain and dysaesthesia in the course of a peripheral nerve at one of the lower limbs and feet or 
more rarely at one of the hands and underarms. Weakness develops, thereafter, within hours or 
days. Gradually more nerves become involved and the clinical picture becomes symmetrical. 
This type of rheumatoid peripheral neuropathy is caused by vasculitis of small or medium-sized 
epineural vessels. The vascular changes resemble that of panarteritis nodosa.
In a retrospective investigation, Puechal et el (1995)71studied the clinical features of 32 patients 
with RA, peripheral neuropathy, and vasculitis established by nerve or muscle biopsy. Nearly 
50%  of  the  patients  had  a  predominantly  sensory  neuropathy.  Others  had  a  sensorimotor 
polyneuropathy,  a  predominantly  motor  neuropathy,  or  mononeuritis  multiplex,  which 
demonstrated that all these types of neuropathies could potentially be caused by vasculitis. It is 
of interest that in a retrospective investigation of 61 patients with RA and histologically proven 
vasculitis done by voskuyl et al(1996)70, 12% had mononeuritis multiplex and 15% had distal 
sensory neuropathy. These observations indicate, but do not prove that all forms of neuropathy, 
including mild sensory neuropathy,  may be caused by vasculitis.  No less  than 25% of the 
patients of Puechal et al had a relapse after recovery of their neuropathy. Vasculitic neuropathy, 
in this study, was a feature of long standing seropositive RA with rheumatoid nodules; the 
range of RA disease duration was, however, wide. The five year survival rate of patients with 
rheumatoid vasculitis varies in different studies: in Puechal et al71 it was 57% and in Voskuyl et 
al70 it was 67%.
DIAGNOSIS AND MANAGEMENT
Patients with mild sensory neuropathy should be examined for evidence of vasculitis. There is a 
reasonable chance that  vasculitis  can be discovered by the presence of skin lesions71.  Less 
frequent are kidney or GIT lesions. Nail fold infarcts and splinter haemorrhages are also due to 
vasculitis, but only of small arteritis. These are often present, but need no therapy as they tend 
to recover spontaneously. They should not be considered as signs in support of a vasculitic 
origin of neuropathy. On its own, mild sensory neuropathy requires regular careful control. The 
available data suggest that one should wait and see what happens, as spontaneous recovery 
seems  to  occur  in  at  least  some  cases.  When  there  is  a  progress  towards  a  sensorimotor 
neuropathy or in cases of mononeuritis multiplex, invasive diagnostic methods should be used 
and aggressive therapy should be started without delay. Muscle biopsies are at least as often 
diagnostic as sural nerve biopsies and are to be preferred as they cause disagreeable sequelae 
less  often  than  sural  nerve  biopsies.  Patients  with  rheumatoid  vasculitis  and  severe  organ 
involvement  are  likely  to  benefit  from  prompt  initiation  of  therapy  with  high  dose 
corticosteroids and cytostatic agents70. Luqmani et al(1994)prefer, however, intermittent high 
dose  pulses  of  cyclophosphamide,  initially  at  two  weeks  intervals,  with  low  dose  oral 
corticosteroids as supportive therapy. With this strategy, remission is obtained within months, 
following which maintenance therapy is required. However ideal medication for maintenance 
therapy is not available yet. Azathioprine does not sufficiently prevent relapses and low dose 
corticosteroids have too many side effects.
COMPRESSION NEUROPATHIES
CARPAL TUNNEL SYNDROME
Compression of median nerve in the carpal tunnel is frequently seen in RA. In their prospective 
longitudinal  investigation  of  102  patients  of  RA  of  recent  onset,  Fleming  et  al  (1976)72 
registered median nerve compression in 52% of patients overall. Other authors reported slightly 
lower percentages. Patients complain about numbness and tingling in digits1 (thumb) to 4. Pain 
in the median nerve innervated part of the hand may irradiate up to the elbow and even higher. 
Neurological examination may reveal disturbance of skin sensibility in the area innervated by 
the  median  nerve.  Weakness  of  the  thumb  opposition  and  abduction  and  atrophy  of  the 
abductor pollicis brevis may develop later on, but may not be easy to assess in RA patients. The 
laboratory technique that  is used to confirm is  comparison of sensory conduction from the 
fourth finger along the median nerve with sensory conduction from the same finger along the 
ulnar  nerve73.  Therapy  is  conservative  when  the  complaints  are  slight  and  includes  local 
injection of corticosteroids in case of active carpal synovitis. When the complaints are more 
severe or when there is evidence of neurogenic thumb weakness surgery is required.
CRITERIA FOR DIAGNOSIS FOR CARPAL TUNNEL SYNDROME:
The diagnostic criteria for CTS includes a distal motor latency more than 4.3 ms for median 
motor nerve; motor or sensory nerve conduction velocity less than 45m/s and of more than 0.5 
ms latency difference in comparative test  on the other side.
TARSAL TUNNEL SYNDROME
The tibial nerve may become compressed behind and below the medial side of the ankle where 
it  passes  under  the flexor  retinaculum.  Clinical  manifestations are infrequent  and comprise 
pain,  tingling,  and  numbness  of  toes  and  the  soles75.  The  diagnosis  requires 
electrophysiological  confirmation.  The  tibial  nerve  divides  in  the  tunnel  in  two  or  three 
branches. Not all these branches need to be compressed to the same degree. When only one of 
the branches is involved, differentiation is necessary of tarsal tunnel syndrome from plantar 
nerve compression distal to the tarsal tunnel, and additional nerve conduction studies which are 
not easy to perform are required76.
FINGER DROP BY POSTERIOR INTEROSSEUS NERVE ENTRAPMENT
The motor branch of the radial nerve separates from the sensory branch at the level of the 
elbow and passes below the elbow between the superficial and the deep part of the supinator 
muscle. At the site of entrance in the supinator muscle, the nerve may be compressed by the 
fibrous arch of the superficial part of the supinator or by the extensor carpi radialis. It may be 
compressed, at a slightly higher level, by fibrous bands, which may form the radialis tunnel. In 
all these cases, the main symptom is very characteristic, and comprises inability to extend the 
fingers due to weakness of the extensor digitorum communis muscle and the extensor pollicis77. 
Wrist extension is usually preserved and sensibility remains intact. This can be confirmed by 
electromyography.  In  patients  with  RA,  the  nerve  is  compressed  or  stretched  by  bulging, 
proliferative elbow synovium, which is often palpable and best visualized by MRI78. Treatment 
with  local  intra-articular  steroids,  NSAIDS  or  both  has  been  successful  in  several  cases. 
Surgical decompression is advised when medical treatment is unsuccessful.
COMPRESSION OF OTHER NERVES
Compression of nerves at other sites is possible but exceptional. All cases of mononeuropathy 
in  patients  with  RA  deserve  accurate  diagnosis,  as  they  may  in  fact  be  the  onset  of 
mononeuritis multiplex.
NEUROPATHY SYMPTOM SCORE
NSS:
3-4 = mild symptoms
5-6 = moderate symptoms
7-10 = severe neuropathic symptoms
* In each point column, the maximum score can be given only once.
NEUROPATHY DEFICIT SCORE
NDS:
3-5 = mild neuropathic deficits
6-8 = moderate neuropathic deficits
9-10 = severe neuropathic deficits
FUNCTIONAL GRADING  : 
ACR  CLASSIFICATION  CRITERIA  FOR  FUNCTIONAL  STATUS  IN  RHEUMATOID 
ARTHRITIS
Class I: Completely able to perform usual activities of daily living (self-care, vocational, 
and avocational)
Class II: Able  to  perform  usual  self-care  and  vocational  activities,  but  limited  in 
avocational activities
Class III: Able  to  perform  usual  self-care  activities,  but  limited  in  vocational  and 
avocational activities
Class IV: Limited ability to perform usual self-care, vocational, and avocational activities.
Self-care activities include dressing, feeding, bathing, grooming, and toileting. Avocational 
(recreational and/or leisure) and vocational (work, school, homemaking) activities are patient-
desired and age- and sex-specific. 
RADIOLOGICAL GRADING
 RAU AND HERBORN MODIFICATION OF THE LARSEN METHOD.
Thirty two joints are evaluated: eight PIPS, two IP of the thumbs, 10 MCP, two wrists, and 10 
MTP. The six stages are defined as follows: 0 = normal; 1 = soft tissue swelling and/or joint 
space narrowing/subchondral osteoporosis; 2 = erosions with destruction of the joint surface 
(DJS) <25%; 3 = DJS 26–50%; 4 = DJS 51–75%; 5 = DJS >75%. The score ranges from 0 to 
160. In this modification the stages are described as a quantitative measure of the destroyed 
joint surface area and can therefore be applied more easily.
IMPORTANT STUDIES ABOUT RHEUMATOID NEUROPATHY:
The important studies that had been done about neuropathy in Rheumatoid arthritis are listed 
below as short abstracts. 
PERIPHERAL  NEUROPATHY  WITH  NECROTIZING  VASCULITIS  IN 
RHEUMATOID ARTHRITIS
Xavier Puéchal , Gerard Said, Pascal Hilliquin, Joel Coste, Chantal Job-Deslandre, Catherine  
Lacroix, Charles J. Menkès,  Paris, France.
 ABSTRACT   
Objective. To examine the clinic pathologic features of the noncompressive neuropathies in 
rheumatoid arthritis (RA).
Methods. We  studied  32  patients  with  RA and  peripheral  neuropathy  whose  nerve  and/or 
muscle  biopsy  specimens  exhibited  necrotizing  vasculitis.  Morphologic  analysis  of  nerve 
specimens included light and electron microscopy studies and teased fiber preparation. Survival 
was evaluated, and the prognostic values of clinical, biologic, and pathologic features were 
assessed by Cox proportional hazards model. A prognostic assessment based on the significant 
variables was devised to estimate the probability of survival of any individual patient.
Results. Epi  and/or  perineurial  vasculitis  was  observed with the  same frequency in  the  17 
patients with sensory and motor deficit and the 15 patients with sensory neuropathies and was 
associated with axonal degeneration of an average of 77.7% of the nerve fibers.  The mean 
follow up was 7.2 years, and the overall survival rate at 5 years was 57%. A full prolonged 
remission of the vasculitis was observed in 53% of the patients relapse occurred in 25%. The 
factors correlated with mortality, in decreasing order of significance, were clinical cutaneous 
vasculitis (P = 0.0003), neuropathy affecting 3 or 4 limbs (P = 0.03), and depressed level of C4 
(P <  0.05).  The  prognostic  assessment  indicated  a  wide  range  of  5-year  probabilities  of 
survival, from <1% to 93%.
Conclusion. Necrotizing vasculitis is responsible for the different patterns of noncompressive 
neuropathies  in  RA,  including  mononeuritis  multiplex  and  distal  symmetric  sensory  or 
sensorimotor neuropathy. Cutaneous vasculitis, multifocal neuropathy, and depressed C4 level 
were the 3 independent variables which best  predicted mortality.  We propose a prognostic 
assessment according to these variables, to stratify patients to receive more aggressive or less 
aggressive therapy.
NEUROLOGIC COMPLICATIONS OF RHEUMATOID ARTHRITIS. 
Rheum Dis Clin North Am. 1993 Nov; 19 (4):955-73
Chang DJ, Paget SA. Hospital for Special Surgery, New York Hospital, New York.
Neurologic complications are common extraarticular manifestations of RA, involving both the 
peripheral and central nervous systems. Because RA patients suffer from pain, stiffness, and 
weakness, the detection of neurologic impairment is often difficult. Thus, close vigilance and 
thoughtful use of various diagnostic methods will help in the early diagnosis of cervical spine 
involvement,  compression  neuropathies,  peripheral  neuropathies,  myopathies,  and  central 
nervous  system  involvement.  Prompt  and  timely  interventions  may  prevent  permanent 
neurologic sequelae.
THE  FREQUENCY  OF  CARPAL  TUNNEL  SYNDROME  IN  PATIENTS  WITH 
RHEUMATOID ARTHRITIS
Mehmet Ufuk Aluclu, M.D., Department of Neurology Turkey 
Abstract
Objective: Rheumatoid  Arthritis  (RA)  may  be  associated  with  vasculopathy,  peripheral, 
autonomic and entrapment neuropathy. In this study, carpal tunnel syndrome (CTS) in patients 
with  RA  was  investigated.  
Subjects  and Method: 40  adult  patients  (totally  eighty  hands)  with  RA according  to  the 
revised criteria of American College of Rheumatology and 20 healthy volunteers (totally forty 
hands)  for  control  group  were  included  into  the  study.  Nerve  conduction  velocity  was 
performed  to  the  both  groups.  
Results: Carpal tunnel syndrome (usually in sensorimotor axonopathy form) was determined in 
20 hands (25%) of the patients with RA but it was not found in the control group. The three 
hands had minimal CTS (3.75%), five hands had mild CTS (6.25%), five hands had moderate 
CTS  (6.25%)  .
Conclusions: In  this  study,  the  prevalence of  CTS in patients  with RA may be high.  We 
consider that treatment of CTS by medical and/or surgery methods in RA patients will decrease 
complaints and increase life quality. Therefore, we recommend that an electroneurophysiologic 
examination should be performed in all patients with RA as routine diagnostic procedure. 
TARSAL  TUNNEL  SYNDROME  AND  PERIPHERAL  NEUROPATHY  IN 
RHEUMATOID DISEASE 
Annals of the Rheumatic Diseases, 1983, 42, 128-131, Loius Mcguigan, David Burke, Anthony 
Fleming. The Prince Henry Hospital, Sydney , Australia
SUMMARY 
Thirty  patients  with  classical  or  definite  rheumatoid  disease  (RD)  with  foot  pain  and 
radiologically  demonstrated  erosions  were  studied  electro  diagnostically  to  ascertain  the 
frequency of the tarsal tunnel syndrome and peripheral neuropathy. Four patients (13.3%) had 
evidence  of  the  tarsal  tunnel  syndrome.  The  electrical  abnormalities  were  mild  and 
unassociated  with  specific  clinical  features.  Two patients  (66  %)  had  evidence  of  sensory 
peripheral neuropathy. There may be an appreciable frequency of clinically unsuspected tarsal 
tunnel syndrome in RD.
INTERSTITIAL LUNG DISEASE AND NEUROPATHY AS PREDOMINANT EXTRA-
ARTICULAR  MANIFESTATIONS  IN  PATIENTS  WITH  RHEUMATOID 
ARTHRITIS: A PROSPECTIVE STUDY
Anurag  Bharadwaj,  Nigil  Haroon,  Department  of  Immunology-Rheumatology,  Kasturba 
Medical College, Manipal, India
SUMMARY
Background: Rheumatoid arthritis (RA) patients with extra-articular manifestations (ExRA) 
have a severe course of the disease and higher mortality. Indian patients are considered to have 
a low prevalence of ExRA.  We prospectively assessed ExRA in patients with rheumatoid 
arthritis from southern India.
Material/Methods: 140 RA patients were qualified for the study. Patients with confounding 
factors  were  excluded.  A  detailed  history  and  clinical  examination  was  performed.  Two 
independent  investigators  made  a  thorough  search  with  relevant  investigations  for  ExRA, 
according  to  well-defined  criteria.  Results:  At  least  one  ExRA was  present  in  36  patients 
(25.7%). The predominant ExRA (9.29%) was Interstitial Lung Disease (ILD). 12 patients had 
neuropathy  (8.57%).  5  patients  had  eye  involvement,  while  3  had  cutaneous  vasculitis.  4 
patients  had rheumatoid nodules,  and 1 had amyloidosis.  The median age at  diagnosis and 
duration of disease were significantly higher in patients with ExRAs than in those without. 
Deformities and the use of steroids were more common in the ExRA cohort.
Conclusions: The present study shows a high prevalence of ILD and neuropathy as ExRAs in 
our population. A more extensive investigative protocol is warranted for picking up milder 
presentations of these serious manifestations. 
NEUROPATHY IN RHEUMATOID ARTHRITIS 
Nadkar  MY,  Agarwal  R,  Samant  RS,  Chhugani  SJ,  Idgunji  SS,  Iyer  S,  Borges  NE   
J Assoc Physicians India 2001 Feb.:217-20.
BACKGROUND: Paucity of Indian literature on rheumatoid neuropathy creates a lacuna in 
the  critical  evaluation  and  discussion  of  the  subject.  We  did  this  study  to  find  out  the 
incidence and pattern of neuropathy and to correlate it  with disease parameters  and other 
extra-articular  involvement.  
MATERIAL  AND  METHODS: We  studied  31  patients  of  rheumatoid  arthritis  (RA) 
classified  by  ACR criteria.  Electromyography  and nerve  conduction  studies  (EMG/NCV) 
were done in all the patients apart from routine laboratory and radiological investigations. 
Electrocardiograph  (ECG),  pulmonary  function  tests  (PFT)  and  ophthalmological 
examinations  were  also  carried  out  to  ascertain  extra-articular  involvement.  
RESULTS: Ten out of 31 RA patients had neuropathy of which five each were overt and sub 
clinical respectively. Only one patient had entrapment neuropathy. Four of the ten patients 
had  pure  motor  neuropathy  whereas  the  other  six  were  sensori-motor  neuropathies.  Four 
patients had mononeuritis multiplex and five had symmetrical peripheral neuropathy. Nine of 
the ten neuropathic patients had RA for more than 2 years. Seven patients had other extra-
articular  features  along  with  neuropathy.  
CONCLUSIONS: One-third  of  patients  with  RA have  evidence  of  neuropathy.  Disease 
parameters such as activity, rheumatoid factor and functional and radiological grade do not 
correlate  with  neuropathy.  Non-entrapment  sensori-motor  type  of  neuropathy  is  the  most 
common type.
CRANIAL  AND  PERIPHERAL  NEUROPATHY  IN  RHEUMATOID  ARTHRITIS 
WITH SPECIAL EMPHASIS TO II, V, VII, VIII AND XI CRANIAL NERVES
  Sherifa A. HAMED, Eman A. HAMED , Amal M. ELATTAR , Mohamed S.   AbdeL  RAHMAN 
and Nabila F. AMINE . Egypt. 
Background: Cranial neuropathy in rheumatoid arthritis (RA) is relatively rare compared to 
the frequently reported peripheral neuropathy.
Methods: We  investigated  the  occurrence  of  subclinical  cranial  and  peripheral  nerve 
involvement in 55 patients with RA.
Results: Patients had a mean age of 43.1 years and a mean duration of illness of 6.4 years. All 
patients presented with electrophysiological findings suggestive of peripheral neuropathy. In 
addition, 69.1% of them had entrapment neuropathies, in which carpal tunnel syndrome was 
the most common (54.6%). Sensorimotor neuropathy at sites other than usual entrapment sites 
was  diagnosed  in  70.9%,  while  bilateral  distal  sensory  neuropathy  in  lower  limbs  was 
identified  in  29.1%.  Among  cranial  nerves  examined,  optic  and  vestibulocochlear 
neuropathies were common (29.1% of eyes and 40% of ears examined).  Spinal accessory 
neuropathy  was  reported  in  21.8% of  records.  Neither  facial  nor  trigeminal  nerves  were 
affected.  Electrophysiological  characteristics  of neuropathies were indicative of axon loss. 
Significant  association  was  identified  between  neuropathy  and  patients’  ages  (P < 0.01), 
duration of the illness (P < 0.001), presence of rheumatoid nodules (P < 0.001) and disease 
stages (P < 0.001).
Conclusions: Our  results  indicate  that  cranial  and  non-compressive  neuropathies  are  not 
uncommon in  RA.  This  extends  the  pathologic  disease  spectrum.  We do not  confirm,  but 
suggest  the contribution of chronic immune-mediated vasculitis and/or neurotoxicity in RA 
neuropathies. Of clinical importance, subclinical neuropathy may never progress and/or be of 
clinical significance, which contradicts that  of comparable diseases,  such as systemic lupus 
erythematosus.  Advances  in  genetics  implicate  a  complex immune genetics  which controls 
susceptibilities and adaptive molecular mechanisms as a culprit of phenotypical heterogenicity 
among related diseases.
SUBCLINICAL  PERIPHERAL  NERVE  INVOLVEMENT  IN  PATIENTS  WITH 
RHEUMATOID ARTHRITIS
B. Lanzillo , N. Pappone , C. Crisci , C. Di Girolamo , R. Massini , G. Caruso 
Italy
ABSTRACT
Objective: Clinical involvement of the peripheral nervous system is uncommon in rheumatoid 
arthritis (RA); the most common disorders are multiple mononeuritis, sensorimotor neuropathy, 
and entrapment neuropathy. This study was undertaken to investigate the occurrence of electro 
physiologically evident peripheral nerve involvement in RA patients without a clinical history 
of  peripheral  nerve  involvement.
Methods: Forty RA patients were examined neurologically and electro physiologically, and 
sural  nerve  biopsies  were  performed  in  4.
Results: No patient reported symptoms or signs of peripheral nerve involvement. Twenty-six 
patients  (65%)  exhibited  electro  physiologic  findings  consistent  with  a  sensorimotor 
neuropathy (in 2 of them a carpal tunnel syndrome was also present), while 3 patients showed 
isolated carpal tunnel syndrome. There was a moderate loss of myelinated fibers in 3 of the 4 
nerve biopsy samples, and all showed an increased number of endo- and perineurial vessels and 
some  signs  of  axonal  degeneration.
Conclusion: Patients  with  RA  may  have  electro  physiologic  and  histologic  findings  of 
peripheral  nerve  damage,  even  in  the  absence  of  clinical  evidence  of  peripheral  nerve 
involvement.
THE  ELECTRONEUROPHYSIOLOGICAL  EVALUATION  OF  RHEUMATOID 
ARTHRITIS PATIENTS 
A. Sivri and F. Güler-Uysal  , Turkey
ABSTRACT 
 In Rheumatoid Arthritis  (RA),  one clinical  hallmark of the vasculitis  is  the appearance of 
neurological  findings.  However,  it  is  often  difficult  to  diagnose  these  slight  or  early 
neuropathies and the study of the peripheral neuromuscular system is often made difficult by 
symptoms resulting from pain in the joints,  and limitations of movement.  It  is  nevertheless 
often  possible,  by  means  of  electroneuromyography to  show objectively  the  existence  and 
distribution  of  even  sub  clinical  neuropathies.  In  order  to  evaluate  the  neurophysiological 
functions  of  RA patients  by  means  of  the  peripheral  nerve  conduction  and somatosensory 
evoked potential studies, 33 RA patients and 20 healthy controls were included in this study. 
Two (6%) patients were found to have carpal tunnel syndrome, while 6 (18%) patients had 
mononeuritis multiplex. Delayed N12, N13, N1 and P1 latencies were detected in 6 (18%) of 
33 RA patients suggesting central nervous system involvement with intact peripheral nervous 
system.  Our  results  confirm  earlier  observations  that  symptoms  of  neuropathy  are  fairly 
common in cases of RA without there being any clear correlation with any clinical variable. 
Therefore,  the  inclusion  of  an  electroneuro-physiologic  examination  of  the  RA patients  is 
recommended in routine diagnostic procedure.
SENSORY  NEUROPATHY  IN  RHEUMATOID  ARTHRITIS:  AN 
ELECTRONEUROGRAPHIC STUDY. 
Scand J Rheumatol. 1981; 10(2): 81-4 .Lang AH, Kalliomaki JL, Puusa A, Halonen JP. 
In  a  selected series  of  twenty-three  RA patients,  aged  from 23 to  56  years,  mean 41,  the 
neurophysiological  functions  of  six  sensory  nerves  were  measured  and  the  results  were 
correlated with clinical and laboratory data. Significant changes in the functions of one or more 
nerves were found in 10 patients, 2 of whom had no symptoms of clinical neuropathy. There 
was  a  highly  significant  correlation  between  neurophysiological  symptoms  and  clinical 
neuropathy  symptoms,  although  the  combination  of  the  clinical  and  electrophysiological 
findings  was  variable.  On  the  other  hand,  there  was  no  significant  correlation  between 
neurophysiological/neurological  findings  and  clinical/laboratory  data  (age,  sex,  duration  of 
disease, stage of disease, rheumatoid factor and erythrocyte sedimentation rate). Manifest or 
sub-clinical mono-neuropathies in n. medianus were found in 5 patients. In the light of these 
results it would seem in order to recommend the inclusion of an electro-neurophysiological 
examination of the median nerves of RA patients in routine diagnostic procedures.
LATENT  NEUROPATHY  IN  RHEUMATOID  ARTHRITIS 
ELECTROPHYSIOLOGICAL STUDY OF 45 CASES 
Minerva Med. 1982 Mar 3; 73(9); 473-8 .Canesi B, Colombo S, Marobbio C, Rossi AF. 
Thirty  (88.2%)  of  thirty  four  patients  with  rheumatoid  arthritis  showed evidence  of  latent 
neuropathy, as judged by the following tests: measurements of motor and sensory conduction 
velocity;  analysis  of single motor  units  at  various sites  and under  different  conditions.  All 
patients demonstrating electrophysiological signs of involvement of nervous functions showed 
no clinical signs of peripheral neuropathy. On the basis of the present results it is proposed that 
neurophysiological  alterations  could  depend  on  a  widespread  (immunologically  mediated) 
injury of the axonic membrane.
                          MATERIALS AND METHODS
This study was done at the Institute of Neurology, Government General Hospital, Chennai in 
collaboration with the Department of Rheumatology.
TYPE OF STUDY
This study was designed as a non randomized prospective study.
STUDY PERIOD.  
The study was conducted during the period between February 2006 and March 2007.
STUDY POPULATION.
Patients  who  came  to  the  Rheumatology  Outpatient  Unit  and  those  of  the  referred 
rheumatological  cases,  with neurological  complaints,  were taken up for this  study. Patients 
were selected based on Inclusion and Exclusion criteria. 
INCLUSION CRITERIA
Patients  with  Rheumatoid  arthritis  who  strictly  fulfilled  the  1988  revised  criteria  ACR 
classification criteria for Rheumatoid arthritis. Both, the patients with and without symptoms 
suggestive of neuropathy were included.
EXCLUSION CRITERIA
Patients with diabetic mellitus, hepatic/renal diseases, leprosy, chronic drug abuse or any other 
known causes of neuropathy were excluded.
STUDY PROTOCOL.
Clinical  data  was  collected  from  patients  in  a  systematic  manner  and  noted  down  in  a 
standardized proforma. 
Detailed  history  regarding  duration  and  progression  of  rheumatoid  arthritis  was  noted. 
Functional impairment was graded as per ACR criteria. History suggestive of neuropathy with 
its duration, symptoms, distribution, onset, progression and relation to therapy were also noted. 
Complete neurological examination including power, tone, sensations and reflexes was done in 
all the patients. Each patient was given a Neuropathy Symptom Score (NSS) and Neuropathy 
Deficit Score (NDS) score after the clinical examination. Other extra-articular manifestations, 
if any were also taken down.
Following investigations were carried out in all  patients. The list included Complete Blood 
Count,  ESR,  CRP,  RF,  FBS,  blood  urea,  creatinine,  calcium,  phosphorus,  LFT,  HIV  and 
radiography  of  the  affected  joints.  ECG,  PFT,  ophthalmological  evaluations  were  done 
whenever necessary to look for extra-articular manifestations.
Electro diagnostic protocol, as recommended by AAEM was used. Neurophysiological studies 
were performed by RECORDERS & MEDICARE SYSTEMS EMG. EP MARK – II, EMG 
machine, a 4channel electrophysiological device. Nerve conduction studies in the upper limbs 
included sensory and motor conductions of ulnar and median nerves. In the lower limbs motor 
conductions in peroneal and tibial nerves & sensory conduction in sural nerve were done in all 
the patients.  The temperature of the room was maintained at 22-24ºC during all  processes. 
Standardized  nerve  conduction  techniques  were  used.  Conventional  methods  using  surface 
electrodes  for  motor  conduction  and  ring  electrodes  for  sensory  conduction  were  used. 
Latencies were measured from initial deflection of action potential in motor and at peak of 
negative spike in sensory studies. Amplitude represented distance between isoelectric trace and 
negative peak in sensory and peak to peak in motor conduction studies. Standardized criteria 
were used to diagnose carpal & tarsal tunnel syndrome.
STATISTICS
All results were presented as mean ± S.D. The Chi Square test was used for statistical analysis. 
The level of significance was set at P value of 0.05.
RESULTS
Total number of patients who fulfilled the inclusion and exclusion criteria was 59. Out of them 
14(23.72%) patients had features of neuropathy. 
The mean age of the 59 patients was 38.97yrs (range 20 to 67yrs).The mean age of patients 
with neuropathy was however 42.78yrs (range 26 to 67yrs).
AGE IN 
YEARS
NO. OF PATIENTS PERCENTAGE (%)
20-29 2 14.28
30-39 4 28.57
40-49 5 35.71
50-59 2 14.28
≥60 1 7.14
AGE RANGE NEUROPATHY
PRESENT
NEUROPATHY
ABSENT
P VALUE
20-49 11 40
50-70 3 5 0.3217
Only ten of the patients were males. The incidence of neuropathy was higher in males than 
females. Five out of ten (50%) and nine out of 49 (18.36%) had neuropathy. 
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Duration of RA ranged from 6 months to 15 yrs.Duration of RA was ≤2 in four (28.57%) 
patients with neuropathy; whereas five (35.71%) had disease duration of 3-5 years and four 
(28.57%) had disease for more than 5 years.
DURATION IN YRS NO. OF PATIENTS PERCENTAGE (%)
≤2 4 28.57
3-5 5 35.71
6-10 3 21.42
>10 2 14.28
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CHART. 3. SEX DISTRIBUTION – II
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Out  of  the  fourteen  patients  with neuropathy,  only  three  (21.42%) were  sub  clinical.  Rest 
(78.57%) had overt neuropathy.
About the pattern of neuropathy, three (21.42%) had entrapment neuropathy and the remaining 
eleven  (78.57%)  had  non  entrapment  neuropathies.  Among  the  eleven  patients  with  non 
entrapment neuropathies six (42.85%) had sensorimotor type of neuropathy; three (21.42%) 
had  pure  sensory  neuropathy;  one  had  mononeuropathy  and  another  had  mononeuropathy 
multiplex respectively. All the three entrapments were in the carpal tunnel.
PATTERN NO.OF 
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PERCENTAGE (%)
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                          CHART . 5. PATTERN OF NEUROPATHY.
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All the non entrapment neuropathies were of axonal type.
RA functional class was I or II in five (35.71%) and III or IV in nine (64.28%) patients.
Radiological grading was I, II, III, and IV in six, four, three and one patient respectively.
Rheumatoid  factor  was  positive  in  ten  (71.42%)  patients  with  neuropathy,  while  in  four 
(28.57%) it was negative.
R.F NO. OF PATIENTS PERCENTAGE
POSITIVE 10 71.42
NEGATIVE 4 28.57
C reactive protein reflecting the activity of the disease as found to be raised in eleven (78.57%) patients 
with neuropathy.
CRP NO. OF PATIENTS PERCENTAGE
POSITIVE 11 78.57
NEGATIVE 3 21.42
Erythrocyte sedimentation rate was raised in  twelve (85.71%) patients,  with an average of 
60.25mm at the end of first hour.
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CHART. 10. ESR VS NEUROPATHY.
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Out  of  the  59 patients,  sixteen (27.11%) had extra-articular  manifestations  which included 
fourteen (23.72%) with neuropathy, five (8.47%) with pulmonary affection as judged by PFT 
and  one  (1.69%)  had  cardiac  involvement.  Neuropathy  with  pulmonary  involvement  was 
present in three patients and only one patient had all three system affection.
All the patients with neuropathy had received aspirin. Three had received methotrexate and one 
had prednisolone.
                                                      DISCUSSION
Internationally, the overall incidence of neuropathy in Rheumatoid arthritis in different studies 
had varied from 40% to 70%65,70. In an Indian study done in 1991 by Kar et al86, the incidence 
was 20%. Nadkar et al84 published a study in 2001, where they quoted an incidence of 32%. In 
our present study, the overall incidence of neuropathy is 23.32%, which is quite comparable 
with the Indian studies.
In the Kar et al study86, the incidence of overt neuropathy was only 5.7% with the rest being 
sub clinical involvement. Nadkar et al84 showed equal (50%) incidence of overt and sub clinical 
neuropathy. But our study shows high incidence of overt neuropathy  (78.57%).
The  incidence  of  entrapment  neuropathy  is  reportedly  more  common than  non-entrapment 
variety, comprising 50-90% of total neuropathy in RA in various studies while non-entrapment 
neuropathy is reported in 10-50% of the patients with rheumatoid neuropathy64. But in Nadkar 
et al84 study the incidence of entrapment neuropathy was very low (10%). Our study also shows 
similar  low incidence  of  entrapment  neuropathy.  There  is  no  apparent  reason for  the  low 
incidence of entrapment neuropathy in our study.
It is believed that the mean age at onset of neuropathy does not correlate with the presence, 
severity or the type of neuropathy. It has been reported to vary widely from less than 40 years 
to  more  than  70  years2,14.  In  this  study,  patients  having  rheumatoid  neuropathy  have  ages 
ranging from 26 years to 67yrs, with an average of 42.78yrs.
Most series report that male patients of RA have a higher incidence of rheumatoid neuropathy 
than female patients39, 64, 72, 86. The male to female ratio in various reports is found to range from 
0.5:1 to 2.6:1, with most studies having a ratio of around 1:1.This is in contrast to the general 
population of  RA where  females predominate by at  least  2:1.  This  male preponderance of 
rheumatoid neuropathy is also true of other extra-articular manifestations of RA86. In this study 
also, male rheumatoid patients are more susceptible to get neuropathy. In statistical analysis, 
male sex was found to be statistically correlated with the occurrence of neuropathy in RA.
Giovanni  et  al  (2006)60 had  published  in  their  study  a  significant  correlation  between 
occurrence of peripheral neuropathy and Neuropathy Deficit Score but not with the Neuropathy 
Symptom  Score.  In  this  study  too,  there  is  a  significant  correlation  between  NDS  and 
occurrence of neuropathy, while the NSS did not show any correlation.
Several authorities have reported that extra-articular features including neuropathy are related 
to the duration of disease. The average duration of RA before the development of neuropathy 
has been found to vary from 4.5-12 years with the duration of RA ranging from 3 months to 47 
years39,  64,  72,  86.  In  most of  the series  neuropathy was observed in patients  with duration of 
disease more than 2 years39, 72. In the present study, patients having rheumatoid neuropathy had 
RA ranging from 6months to 15 years, with an average of 3.84yrs.
The most widely held view has been that neuropathy may be related to the severity of RA. 
Gordon58 reported that the highest level  of functional impairment and highest frequency of 
severe articular disease was found in patients with one or more extra-articular features. But, in 
Kar et al86 study there was no correlation between poor functional class and severe disease 
radiologically, with the occurrence of neuropathy in RA. In this study too there is no statistical 
correlation  between  occurrence  of  neuropathy  and  severe  disease  functionally  as  well  as 
radiologically.
It  has been reported that 77-100% of patients with rheumatoid neuropathy are seropositive. 
Agarwal  et  al2 found  that  10%  of  patients  with  rheumatoid  vasculitis  were  seronegative. 
McCombe87 in his study, found significantly higher titers of RF In this study, out of 14 patients 
with  neuropathy,  10  (71.42%)  were  seropositive  while  the  remaining  4  (28.57%)  were 
seronegative.
In most series it is well documented that patients with rheumatoid neuropathy and rheumatoid 
vasculitis have a greater ESR at the time of examination. In this study, 12 patients had a high 
ESR. But both ESR and RF were not significantly correlated with rheumatoid neuropathy.
Gordon58 reported presence of one extra-articular feature in 34% of patients and two or more 
extra-articular features in 42% of patients with rheumatoid arthritis. In the present study, out of 
59 patients of RA, 1 patient had three extra-articular system involvement, three had 2 extra-
articular system involved and 11 had only one extra-articular system involved.
After  statistically  analyzing  all  the  variables,  only  male  sex  and  NDS  were  found  to  be 
significantly correlated with the occurrence of neuropathy. NDS is a scale based on specific 
neurological examination whereas NSS is a score based on subjective neurological symptoms. 
Hence  lack  of  correlation  between  NSS  and  neuropathy  confirms  that,  in  these  patients 
discernment  between  neuropathic  pain  and  arthritic  pain  may  be  arduous  without  careful 
neurological evaluation. And a significant correlation between NDS and neuropathy means that 
NDS  should  be  incorporated  in  the  initial  evaluation  of  peripheral  nerve  involvement  in 
Rheumatoid arthritis patients. 
                                  CONCLUSIONS
 One fourth of the patients with Rheumatoid arthritis had evidence of neuropathy.
 Non entrapment  neuropathy  was  the  predominant  type  of  neuropathy  among  which 
sensorimotor type was the most common one.
 Among the  disease  parameters,  only male  sex and Neuropathy  Deficit  Score (NDS) 
were found to be significantly correlated with rheumatoid neuropathy.
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PROFORMA
THE  CLINICAL  AND  ELECTROPHYSIOLOGICAL  EVALUATION  OF 
PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS
NAME:
AGE:
SEX:
MIN NO.:
RCC NO.:
DURATION OF RA:
DURATION OF SYMPTOMS OF NEUROPATHY:
FUNCTIONAL GRADE OF RA:
RADIOLOGICAL GRADE OF RA:
NEUROPATHY SYMPTOMS:
NEUROPATHY SIGNS
NSS SCORE:
NDS SCORE:
EXTRA-ARTICULAR MANIFESTATIONS:
R.F.:
ESR:
CRP:
H/O DM:
H/O ALCOHOLISM:
FBS/PPBS:
HIV:
UREA/CREATININE:
NCS:
THERAPY:
                  
   
